Prognostic and predictive factors for response in treatment of breast cancer and other cancers

New discoveries in molecular oncology of cancer and translation of this knowledge into diagnosis and treatment of various cancers are the most important fields of cancer research nowadays. Through researching the molecular tumor markers in different solid tumors and lymphomas and through evaluating their prognostic and predictive value for response to systemic treatment our new findings contribute to a better understanding of molecular oncology and an improved individualized systemic therapy of cancer.

Cancer is the major public health issue in whole developed world. With the ageing of the population, a sustained increase in cancer incidence can also be foreseen. Research in the field of molecular oncology and transfer of this knowledge into routine clinical practice are of utmost importance for good cancer control worldwide. Our research program is structured to allow for research of new prognostic and predictive molecular tumor markers and enables the rapid transfer of knowledge into routine clinical practice in Slovenia. The importance of our research is based on the fact that more than 10.000 new cancer patients are diagnosed in Slovenia each year and the prevalence of the disease is already around 60.000.